• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性颅内狭窄患者的血脂水平与短期复发性脑梗死风险。

Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis.

机构信息

The University of Chicago, Chicago, IL, USA.

University of California at Los Angeles, Los Angeles, CA, USA.

出版信息

J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106141. doi: 10.1016/j.jstrokecerebrovasdis.2021.106141. Epub 2021 Oct 26.

DOI:10.1016/j.jstrokecerebrovasdis.2021.106141
PMID:34710776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8766886/
Abstract

OBJECTIVES

Hyperlipidemia is a strong risk factor for intracranial atherosclerotic disease (ICAD) and clinical stroke recurrence. We explored the effect of serum lipid levels on subclinical infarct recurrence in the Mechanisms of earlY Recurrence in Intracranial Atherosclerotic Disease (MYRIAD) study.

MATERIALS AND METHODS

We included enrolled MYRIAD patients with lipid measurements and brain MRI at baseline and brain MRI at 6-8 weeks. Infarct recurrence was defined as new infarcts in the territory of the symptomatic artery on brain MRI at 6-8 weeks compared to baseline brain MRI. We assessed the association between baseline total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels and recurrent infarct at 6-8 weeks using multivariable logistic regression.

RESULTS

Among 74 patients (mean age 64.2±12.9 years, 59.5% were white, 60.8% men), 20 (27.0%) had new or recurrent infarcts. Mean HDL-C (37.2 vs. 43.9 mg/dL, P=0.037) was lower and TG (113.5 vs. 91.3 mg/dL, P=0.008) was higher while TC (199.8 vs. 174.3 mg/dL, P=0.061) and LDL-C (124.3 vs. 101.2 mg/dL, P=0.053) were nominally higher among those with recurrent infarcts than those without. LDL-C (adj. OR 1.022, 95% CI 1.004-1.040, P=0.015) and TG (adj. OR 1.009, 95% CI 1.001-1.016, P=0.021) were predictors of recurrent infarct at 6-8 weeks adjusting for other clinical and imaging factors.

CONCLUSIONS

Baseline cholesterol markers can predict early infarct recurrence in patients with symptomatic ICAD. More intensive and rapid lipid lowering drugs may be required to reduce risk of early recurrence.

摘要

目的

高血脂是颅内动脉粥样硬化性疾病(ICAD)和临床中风复发的一个强有力的危险因素。我们在 Mechanisms of earlY Recurrence in Intracranial Atherosclerotic Disease(MYRIAD)研究中探讨了血清脂质水平对亚临床梗死复发的影响。

材料与方法

我们纳入了在基线和 6-8 周时进行了血脂测量和脑部 MRI 的 MYRIAD 研究患者。梗死复发定义为在症状性动脉供血区的新梗死在 6-8 周时与基线脑部 MRI 相比。我们使用多变量逻辑回归评估了基线总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)水平与 6-8 周时复发性梗死之间的相关性。

结果

在 74 例患者(平均年龄 64.2±12.9 岁,59.5%为白人,60.8%为男性)中,有 20 例(27.0%)出现新的或复发性梗死。与无复发性梗死者相比,有复发性梗死者的 HDL-C 水平较低(37.2 与 43.9mg/dL,P=0.037),TG 水平较高(113.5 与 91.3mg/dL,P=0.008),TC 水平和 LDL-C 水平略高(199.8 与 174.3mg/dL,P=0.061;124.3 与 101.2mg/dL,P=0.053)。在校正其他临床和影像学因素后,LDL-C(调整后 OR 1.022,95%CI 1.004-1.040,P=0.015)和 TG(调整后 OR 1.009,95%CI 1.001-1.016,P=0.021)是 6-8 周时复发性梗死的预测因素。

结论

基线胆固醇标志物可预测有症状性 ICAD 患者的早期梗死复发。可能需要更强化和更快速的降脂药物来降低早期复发的风险。

相似文献

1
Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis.症状性颅内狭窄患者的血脂水平与短期复发性脑梗死风险。
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106141. doi: 10.1016/j.jstrokecerebrovasdis.2021.106141. Epub 2021 Oct 26.
2
Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.症状性颅内动脉粥样硬化疾病患者早期梗死复发的预测因素。
Stroke. 2021 Jun;52(6):1961-1966. doi: 10.1161/STROKEAHA.120.032676. Epub 2021 Apr 19.
3
Importance of lipid ratios for predicting intracranial atherosclerotic stenosis.脂质比率对预测颅内动脉粥样硬化狭窄的重要性。
Lipids Health Dis. 2020 Jul 4;19(1):160. doi: 10.1186/s12944-020-01336-1.
4
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.脂质测量在心血管疾病管理中的应用:实用建议——国家脂质协会写作组的科学声明。
J Clin Lipidol. 2021 Sep-Oct;15(5):629-648. doi: 10.1016/j.jacl.2021.09.046. Epub 2021 Sep 24.
5
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.乌干达农村家庭艾滋病护理项目中接受一线高效抗逆转录病毒治疗的成年人在24个月内的血脂变化情况。
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):304-11. doi: 10.1097/qai.0b013e31815e7453.
6
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
7
Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.动脉粥样硬化性卒中患者的空腹和非空腹血浆甘油三酯及高密度脂蛋白胆固醇:根据低密度脂蛋白胆固醇的不同特征
Atherosclerosis. 2012 Aug;223(2):463-7. doi: 10.1016/j.atherosclerosis.2012.05.011. Epub 2012 May 19.
8
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.除了低密度脂蛋白胆固醇之外:非高密度脂蛋白胆固醇水平、甘油三酯以及总胆固醇/高密度脂蛋白胆固醇比值对貌似健康的男性和女性冠心病风险的各自影响。
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.
9
Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.脂质与脂蛋白测量及缺血性血管事件风险:弗雷明汉姆研究
Neurology. 2015 Feb 3;84(5):472-9. doi: 10.1212/WNL.0000000000001202. Epub 2015 Jan 7.
10
Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.成人生命历程中血脂浓度的变化轨迹与心血管疾病和全因死亡率的风险:弗雷明汉研究 35 年来的观察结果。
J Am Heart Assoc. 2019 Jun 4;8(11):e011433. doi: 10.1161/JAHA.118.011433. Epub 2019 May 29.

引用本文的文献

1
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population.在新发性短暂性脑缺血发作和轻度缺血性卒中试验(POINT)的试验人群中启动他汀类药物治疗与早期卒中复发情况
J Stroke Cerebrovasc Dis. 2025 Jul;34(7):108349. doi: 10.1016/j.jstrokecerebrovasdis.2025.108349. Epub 2025 May 15.
2
Impact of serum lipid on recurrence of uterine fibroids: a single center retrospective study.血清脂质对子宫肌瘤复发的影响:一项单中心回顾性研究
BMC Womens Health. 2024 Dec 31;24(1):677. doi: 10.1186/s12905-024-03530-0.
3
Association of Dilated Perivascular Spaces With Lipid Indices in Ischemic Stroke Patients.缺血性中风患者中扩张的血管周围间隙与血脂指标的关联。
Cureus. 2022 Sep 5;14(9):e28783. doi: 10.7759/cureus.28783. eCollection 2022 Sep.
4
Risk Factors and Distribution Characteristics of Intracranial and Intracranial Artery Stenosis in Young Sufferers with Ischemic Stroke.青年缺血性脑卒中患者颅内及颅外动脉狭窄的危险因素及分布特征。
Contrast Media Mol Imaging. 2022 Jun 24;2022:9684158. doi: 10.1155/2022/9684158. eCollection 2022.

本文引用的文献

1
Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease.症状性颅内动脉粥样硬化性疾病患者的危险因素控制与早期复发性脑梗死
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105914. doi: 10.1016/j.jstrokecerebrovasdis.2021.105914. Epub 2021 Jun 30.
2
Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.症状性颅内动脉粥样硬化疾病患者早期梗死复发的预测因素。
Stroke. 2021 Jun;52(6):1961-1966. doi: 10.1161/STROKEAHA.120.032676. Epub 2021 Apr 19.
3
Imaging Patterns of Recurrent Infarction in the Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD) Study.颅内动脉粥样硬化疾病早期复发机制(MyRIAD)研究中复发性梗死的影像学模式
Front Neurol. 2021 Jan 21;11:615094. doi: 10.3389/fneur.2020.615094. eCollection 2020.
4
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
5
Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design.颅内动脉粥样硬化性疾病(MyRIAD)早期复发的机制:原理与设计。
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105051. doi: 10.1016/j.jstrokecerebrovasdis.2020.105051. Epub 2020 Jul 11.
6
Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent.使用降脂药物进行积极药物治疗使无症状性颅内动脉狭窄消退。
J Cerebrovasc Endovasc Neurosurg. 2019 Sep;21(3):144-151. doi: 10.7461/jcen.2019.21.3.144. Epub 2019 Sep 30.
7
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.缺血性脑卒中后两种 LDL 胆固醇目标的比较。
N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18.
8
Silent brain infarctions and cognition decline: systematic review and meta-analysis.无症状性脑梗死与认知功能减退:系统评价和荟萃分析。
J Neurol. 2020 Feb;267(2):502-512. doi: 10.1007/s00415-019-09534-3. Epub 2019 Nov 5.
9
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS).依洛尤单抗在急性冠状动脉综合征患者中早期降低 LDL 胆固醇水平的研究(EVOPACS)。
J Am Coll Cardiol. 2019 Nov 19;74(20):2452-2462. doi: 10.1016/j.jacc.2019.08.010. Epub 2019 Aug 31.
10
Intensive Lipid-Lowering Therapy Ameliorates Asymptomatic Intracranial Atherosclerosis.强化降脂治疗可改善无症状性颅内动脉粥样硬化。
Aging Dis. 2019 Apr 1;10(2):258-266. doi: 10.14336/AD.2018.0526. eCollection 2019 Apr.